Corrigendum to: Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Health Promot Perspect. 2020 Mar 30;10(2):98-115. doi: 10.34172/hpp.2020.18

Majid Mobasseri ¹ , Masoud Shirmohammadi ², Tarlan Amiri ³, Nafiseh Vahed ^4,5, Hossein Hosseini Fard ⁵, Morteza Ghojazadeh ⁵ *

Cited by CrossRef: 0

1- Ivasiuk O, Burlaka I, Mityuryayeva-Kornijko I. Duality of development and manifestations of PTSD in children with type 1 diabetes during the war in Ukraine. USMYJ. 2025;152(1):154 [Crossref]

2- Tall S, Prahalad P, Adiels M, Rosengren A, Virtanen S, Maahs D, Knip M. Increased Risk of Type 1 Diabetes in Boys Under the Age of 5 Years During COVID‐19 Lockdowns in Finland, Sweden and Stanford, CA, USA—An Observational Multicenter Study. Diabetes Metabolism Res. 2025;41(6) [Crossref]

3- Alshehri N, Alessa M, Alrasheed A, Alyousefi N, Alwatban L, AlSaif H, Alshehri A. Role of Continuous Glucose Monitoring in Supporting Glycemic Control Among Adolescents with Type 1 Diabetes in Saudi Arabia: A Retrospective Study. Healthcare. 2025;13(5):496 [Crossref]

4- Maddhuri S, Snigdha V, Annapurna V, Rai D, Akhil G, Kalyani S, Bodiga V, Reddy S. The Implication of ENSA, K-ATP Channel Encoding Gene Variations in Type 1 Diabetes in Children of South Indian Population. Ind J Clin Biochem. 2025; [Crossref]

5- Ng S, Tattersall Z, Swain V, Quirk K, Sandhu G, Soni A. Omnipod5 Real-World Data from the First Pediatric Users’ Universal Coverage Under the UK National Health Service. Diabetes Technology & Therapeutics. 2025; [Crossref]